We are live on ! Find out more
OCRX

Ocera Therapeutics, Inc.
OCRX

Delisted

OCRX was delisted on the 8th of December, 2017.

Back to rankings

26 hedge funds and large institutions have $7.22M invested in Ocera Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 2

28% less funds holding

Funds holding: 36 → 26 (-10)

44% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 16

62% less capital invested

Capital invested by funds: $19.2M → $7.22M (-$12M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
26
Holders Change
-10
Holders Change %
-27.78%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
9
Increased
10
Reduced
2
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$2.74M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.15M
3
HP
Hikari Power
Japan
+$318K
4
BlackRock
BlackRock
New York
+$79.4K
5
Citadel Advisors
Citadel Advisors
Florida
+$70.9K

Top Sellers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
-$4.12M
2
IVM
InterWest Venture Management
California
-$2.62M
3
QF
QVT Financial
New York
-$1.9M
4
DM
Deerfield Management
New York
-$1.2M
5
SM
Sabby Management
Florida
-$690K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$2.82M +$2.74M +2,150,000 New
VMI
2
VHCP Management II
New York
$1.59M – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.42M +$1.15M +905,957 +521%
HP
4
Hikari Power
Japan
$328K +$318K +250,000 New
ECM
5
Endurant Capital Management
California
$200K -$94K -73,800 -33%
BCM
6
Bridgeway Capital Management
Texas
$172K – – –
VKH
7
Virtu KCG Holdings
New York
$95K +$37.5K +29,446 +68%
BlackRock
8
BlackRock
New York
$82K +$79.4K +62,374 New
Geode Capital Management
9
Geode Capital Management
Massachusetts
$80K +$688 +540 +0.9%
Citadel Advisors
10
Citadel Advisors
Florida
$73K +$70.9K +55,673 New
PAM
11
Panagora Asset Management
Massachusetts
$66K +$52.5K +41,256 +464%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$46K +$4.62K +3,628 +11%
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$40K – – –
GT
14
Glenmede Trust
Pennsylvania
$36K – – –
Morgan Stanley
15
Morgan Stanley
New York
$36K +$31.7K +24,876 +1,087%
Stifel Financial
16
Stifel Financial
Missouri
$30K -$15.3K -11,987 -35%
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
$26K +$8.72K +6,850 +52%
TSS
18
Two Sigma Securities
New York
$25K +$24.4K +19,180 New
Northern Trust
19
Northern Trust
Illinois
$21K +$3.27K +2,565 +19%
IIA
20
IPG Investment Advisors
California
$19.6K +$2.55K +2,000 +15%
UBS Group
21
UBS Group
Switzerland
$10K +$9.98K +7,837 New
FPF
22
FNY Partners Fund
New York
$8K +$8.15K +6,400 New
Manulife (Manufacturers Life Insurance)
23
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2K – – –
TRCT
24
Tower Research Capital (TRC)
New York
$1K +$127 +100 +14%
AG
25
Advisor Group
Arizona
$1K +$1.27K +1,000 New
1
2

OCRX Hedge Fund Activity: Q1 2017 in Review

26 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Ocera Therapeutics, Inc. (OCRX) for Q1 2017, worth a combined $7.22M — down 62% from $19.2M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of OCRX and 9 opened new positions — a net loss of 7 holders — while 2 trimmed existing stakes and 10 added.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $2.74M. The largest seller was Great Point Partners, exiting entirely with an estimated $4.12M sold.

  • 26 institutional investors held Ocera Therapeutics, Inc. (OCRX) as of Q1 2017, down from 36 in Q4 2016.
  • Funds reported $7.22M of Ocera Therapeutics, Inc. stock for Q1 2017, down 62% quarter-over-quarter.
  • 9 funds opened new Ocera Therapeutics, Inc. positions in Q1 2017 and 16 closed out, a net change of -7 holders.
  • The largest Ocera Therapeutics, Inc. buyer in Q1 2017 was Perceptive Advisors, an estimated $2.74M added.
  • The largest Ocera Therapeutics, Inc. seller in Q1 2017 was Great Point Partners, an estimated $4.12M sold.

Based on aggregated 13F filings for Q1 2017.